Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 9.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 50.40
  • 52 Week Low: 6.75
  • Currency: UK Pounds
  • Shares Issued: 189.93m
  • Volume: 29,604
  • Market Cap: £17.09m
  • RiskGrade: 348
  • Beta: 1.48

Latest ShareCast News

Renalytix terminates formal sale process

By Josh White

Date: Tuesday 20 Aug 2024

(Sharecast News) - Renalytix, a company specialising in artificial intelligence-enabled diagnostics for kidney disease, announced the termination of its formal sale process on Tuesday.

Renalytix test gets US Medicare coverage determination

By Josh White

Date: Friday 14 Jun 2024

(Sharecast News) - Renalytix announced on Friday that Medicare has issued a final local coverage determination (LCD) for its 'kidneyintelX.dkd' testing.

Renalytix surges on takeover approach

By Michele Maatouk

Date: Monday 04 Mar 2024

(Sharecast News) - Renalytix surged on Monday after saying it had received an unsolicited takeover approach from "a large and well-capitalised publicly listed strategic diagnostics company".

Renalytix shares jump on draft US Medicare cover... 09-Feb-2024 ShareCast
Renalytix kidney test claims allowed by US Paten... 06-Oct-2023 ShareCast
Renalytix gets KidneyIntelX included in major cl... 21-Aug-2023 ShareCast
Renalytix launches kidney disease test in Arabia... 21-Jul-2023 ShareCast
Renalytix test gets US FDA marketing authorisation 30-Jun-2023 ShareCast
Renalytix secures expanded coverage in Washingto... 22-May-2023 ShareCast
Renalytix reports positive study on clinical val... 19-Apr-2023 ShareCast
Renalytix rises on publication of positive evide... 29-Nov-2022 ShareCast
Renalytix reports positive outcomes from Mount S... 10-Jun-2022 ShareCast
Renalytix completes financing to support its gro... 08-Apr-2022 ShareCast
Revenue rises, losses widen in first half at Ren... 31-Mar-2022 ShareCast
Renalytix hits patient milestone for kidney and ... 29-Mar-2022 ShareCast
Renalytix launches new US provider access portal 09-Mar-2022 ShareCast
Renalytix presents new clinical data on KidneyIn... 24-Feb-2022 ShareCast
Renalytix inks partnership with Singing River He... 10-Jan-2022 ShareCast
Renalytix inks partnership with the American Dia... 04-Jan-2022 ShareCast
Losses widen as Renalytix achieves revenue in fi... 07-Dec-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 9.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 50.40
52 Week Low 6.75
Volume 29,604
Shares Issued 189.93m
Market Cap £17.09m
Beta 1.48
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.64% above the market average15.64% above the market average15.64% above the market average15.64% above the market average15.64% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Price Trend
86.68% below the market average86.68% below the market average86.68% below the market average86.68% below the market average86.68% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average
Income Not Available
Growth
34.96% below the market average34.96% below the market average34.96% below the market average34.96% below the market average34.96% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

RENX Dividends

No dividends found

Trades for 12-Dec-2024

Time Volume / Share Price
09:36 210 @ 9.50p
09:04 20,969 @ 9.50p
08:00 8,425 @ 9.50p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page